Heart failure monitoring study using a smartwatch and app
Part of Heart & circulation clinical trials.
This study tests a digital tool (smartwatch and app) to detect early signs of heart failure worsening. It may help people with chronic heart failure manage their condition from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic heart failure diagnosed by a doctor.
- You have been hospitalized for heart failure in the past year or have symptoms like shortness of breath with normal activity and high BNP/NT-proBNP levels.
- You speak French.
- You have a smartphone, computer, or tablet with internet access (or a caregiver who does).
- You have health insurance (social security).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
This study tests whether a smartwatch and remote check-ins can help people with acute heart failure and atrial fibrillation manage their health better after leaving the hospital. It may improve recovery and reduce the need for emergency care.
This trial checks whether using a smartphone or tablet to monitor heart failure symptoms from home is feasible and helps people do better. You may be asked to track your symptoms and health data, and the team will see if this approach can work safely.
This study uses a smartphone app to monitor your physical activity and give you personalized feedback. It may help you manage heart failure and stay active safely.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
Hear when a new Heart Failure - NYHA II - IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.